TOP MS is a Study of Multiple Sclerosis Disease Management in Collaboration With Specialty Pharmacies.

Trial Profile

TOP MS is a Study of Multiple Sclerosis Disease Management in Collaboration With Specialty Pharmacies.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2013

At a glance

  • Drugs Glatiramer acetate (Primary) ; Interferon beta-1a; Interferon beta-1a; Interferon beta-1b
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms TOP-MS
  • Sponsors Teva Neuroscience
  • Most Recent Events

    • 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Oct 2012 Results were presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in October 2012.
    • 14 Oct 2011 Results will be presented at the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS and ACTRIMS), according to a Teva Pharmaceutical Industries media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top